Literature DB >> 11261842

Expression of H type 1 antigen of ABO histo-blood group in normal colon and aberrant expressions of H type 2 and H type 3/4 antigens in colon cancer.

N Fujitani1, Y Liu, S Toda, K Shirouzu, T Okamura, H Kimura.   

Abstract

We have immunohistochemically examined the distribution of the H antigens of type 1, type 2 and type 3/4 chains of the ABO(H) histo-blood group system in human normal colon and in colon cancer using three monoclonal antibodies specific for each of the H type 1/2, H type 2, and the H type 3/4 chain. We unexpectedly found that mucosa of the normal colon from secretors but not that from nonsecretors expressed only H type 1 and did not express H type 2 or H type 3/4. The H type 1 was expressed in goblet cells. Positive goblet cells expressing H type 1 were decreased in number progressively from the proximal colon to the rectum. In tumors, 4 (57%) of 7 cancer tissues of the proximal colon from secretors expressed no H type 1, whereas all 8 cancer tissues of the distal colon from secretors expressed H type 1. The aberrant expressions of H type 2 and H type 3/4 (47 and 67%, respectively) were found in cancer tissues from both the proximal and the distal colon. Tumors from nonsecretors did not express any H antigens. Our results suggested that the expression of H type 1 in the normal colon and the aberrant expressions of H type 2 and H type 3/4 in colon cancer tissues were regulated by FUT2-encoded Se type alpha(1,2)fucosyltransferase. However, UEA-I-positive substance(s) rather than H type 2 were uniquely expressed throughout the normal colon and in colon cancers from both secretors and nonsecretors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11261842     DOI: 10.1023/a:1007173722426

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  42 in total

Review 1.  ABH and related histo-blood group antigens; immunochemical differences in carrier isotypes and their distribution.

Authors:  H Clausen; S Hakomori
Journal:  Vox Sang       Date:  1989       Impact factor: 2.144

2.  Characterization of the binding specificity of Anguilla anguilla agglutinin (AAA) in comparison to Ulex europaeus agglutinin I (UEA-I).

Authors:  S E Baldus; J Thiele; Y O Park; F G Hanisch; J Bara; R Fischer
Journal:  Glycoconj J       Date:  1996-08       Impact factor: 2.916

3.  Novel blood group H glycolipid antigens exclusively expressed in blood group A and AB erythrocytes (type 3 chain H). II. Differential conversion of different H substrates by A1 and A2 enzymes, and type 3 chain H expression in relation to secretor status.

Authors:  H Clausen; E Holmes; S Hakomori
Journal:  J Biol Chem       Date:  1986-01-25       Impact factor: 5.157

4.  Molecular basis for secretor type alpha(1,2)-fucosyltransferase gene deficiency in a Japanese population: a fusion gene generated by unequal crossover responsible for the enzyme deficiency.

Authors:  Y Koda; M Soejima; Y Liu; H Kimura
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

5.  Lewis blood group fucolipids and their isomers from human and canine intestine.

Authors:  J M McKibbin; W A Spencer; E L Smith; J E Mansson; K A Karlsson; B E Samuelsson; Y T Li; S C Li
Journal:  J Biol Chem       Date:  1982-01-25       Impact factor: 5.157

6.  Ulex europeus agglutinin I-reactive high molecular weight glycoproteins of adenocarcinoma of distal colon and rectum and their possible relationship with metastatic potential.

Authors:  T Irimura; D M Ota; K R Cleary
Journal:  Cancer Res       Date:  1987-02-01       Impact factor: 12.701

7.  Glycoconjugate with Ulex europaeus agglutinin-I-binding sites in normal mucosa, adenoma, and carcinoma of the human large bowel.

Authors:  S Yonezawa; T Nakamura; S Tanaka; E Sato
Journal:  J Natl Cancer Inst       Date:  1982-10       Impact factor: 13.506

8.  Extensive polymorphism of the FUT2 gene in an African (Xhosa) population of South Africa.

Authors:  Y Liu; Y Koda; M Soejima; H Pang; T Schlaphoff; E D du Toit; H Kimura
Journal:  Hum Genet       Date:  1998-08       Impact factor: 4.132

9.  Distribution of blood group antigens A, B, H, Lewisa, and Lewisb in human normal, fetal, and malignant colonic tissue.

Authors:  M Yuan; S H Itzkowitz; A Palekar; A M Shamsuddin; P C Phelps; B F Trump; Y S Kim
Journal:  Cancer Res       Date:  1985-09       Impact factor: 12.701

10.  Aberrant alpha 1-->2fucosyltransferases found in human colorectal carcinoma involved in the accumulation of Leb and Y antigens in colorectal tumors.

Authors:  S Yazawa; J Nakamura; T Asao; Y Nagamachi; M Sagi; K L Matta; T Tachikawa; M Akamatsu
Journal:  Jpn J Cancer Res       Date:  1993-09
View more
  15 in total

1.  Ectopic expression of blood type antigens in inflamed mucosa with higher incidence of FUT2 secretor status in colonic Crohn's disease.

Authors:  Jun Miyoshi; Tomoharu Yajima; Susumu Okamoto; Katsuyoshi Matsuoka; Nagamu Inoue; Tadakazu Hisamatsu; Katsuyoshi Shimamura; Atsushi Nakazawa; Takanori Kanai; Haruhiko Ogata; Yasushi Iwao; Makio Mukai; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2011-07-05       Impact factor: 7.527

Review 2.  Blood type biochemistry and human disease.

Authors:  D Rose Ewald; Susan C J Sumner
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2016-09-07

3.  Co-expression of CD173 (H2) and CD174 (Lewis Y) with CD44 suggests that fucosylated histo-blood group antigens are markers of breast cancer-initiating cells.

Authors:  Wei-Ming Lin; Uwe Karsten; Steffen Goletz; Ruo-Chuan Cheng; Yi Cao
Journal:  Virchows Arch       Date:  2010-03-19       Impact factor: 4.064

4.  MAb L9E10 to blood group H2 antigen binds to colon cancer stem cells and inhibits tumor cell migration and invasion.

Authors:  Mai Xu; Fan Wang; Jeffrey C Gildersleeve; Samuel Achilefu
Journal:  Hybridoma (Larchmt)       Date:  2010-08

5.  Association of type O blood with pancreatic neuroendocrine tumors in Von Hippel-Lindau syndrome.

Authors:  Allison B Weisbrod; David J Liewehr; Seth M Steinberg; Erin E Patterson; Steven K Libutti; W Marston Linehan; Naris Nilubol; Electron Kebebew
Journal:  Ann Surg Oncol       Date:  2012-02-16       Impact factor: 5.344

6.  Sugar-binding proteins from fish: selection of high affinity "lambodies" that recognize biomedically relevant glycans.

Authors:  Xia Hong; Mark Z Ma; Jeffrey C Gildersleeve; Sudipa Chowdhury; Joseph J Barchi; Roy A Mariuzza; Michael B Murphy; Li Mao; Zeev Pancer
Journal:  ACS Chem Biol       Date:  2012-10-08       Impact factor: 5.100

7.  Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1.

Authors:  Allison B Weisbrod; Naris Nilubol; Lee S Weinstein; William F Simonds; Steven K Libutti; Robert T Jensen; Stephen J Marx; Electron Kebebew
Journal:  J Clin Endocrinol Metab       Date:  2012-10-23       Impact factor: 5.958

8.  Increased expression of a Myc target gene Mina53 in human colon cancer.

Authors:  Kwesi Teye; Makoto Tsuneoka; Nobuyuki Arima; Yoshiro Koda; Yasuhiro Nakamura; Yoichi Ueta; Kazuo Shirouzu; Hiroshi Kimura
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

9.  Association between the ABO blood group and the human intestinal microbiota composition.

Authors:  Harri Mäkivuokko; Sampo J Lahtinen; Pirjo Wacklin; Elina Tuovinen; Heli Tenkanen; Janne Nikkilä; Marika Björklund; Kari Aranko; Arthur C Ouwehand; Jaana Mättö
Journal:  BMC Microbiol       Date:  2012-06-06       Impact factor: 3.605

10.  Higher frequency of secretor phenotype in O blood group - its benefits in prevention and/or treatment of some diseases.

Authors:  Mohamad Salih Jaff
Journal:  Int J Nanomedicine       Date:  2010-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.